<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03706820</url>
  </required_header>
  <id_info>
    <org_study_id>MED-AUTH-3.1/02-05-2018</org_study_id>
    <nct_id>NCT03706820</nct_id>
  </id_info>
  <brief_title>Exercise Hemodynamics in Patients With Pulmonary Fibrosis</brief_title>
  <official_title>Hemodynamic Study of the Pulmonary Circulation in Exercise in Patients With Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the rest and exercise hemodynamics of patients presenting either
      idiopathic fibrotic pulmonary disease or pulmonary fibrosis secondary to connective tissue
      disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with fibrotic pulmonary disease of the above origin will undergo detailed assessment
      of functional status with the following examinations: pulmonary function tests,
      echocardiogram, 6 minute exercise test, cardiopulmonary exercise test (in the absence of
      contra-indications) and finally right heart catheterization. Hemodynamic assessment will take
      place at rest and at exercise following the exercise protocol that was recommended by Herve
      et al (ERJ 2015) using a cycle ergometer at bedside.

      The purposes of the study are:

        1. to evaluate the response of the hemodynamic parameters at exercise compared to the
           resting parameters in this patient group.

        2. to discriminate between precapillary from postcapillary etiology of pulmonary
           hypertension.

        3. to correlate non-invasive parameters of functional limitation with invasive hemodynamic
           parameters.

        4. to assess the prognostic role of exercise induced pulmonary hypertension in the specific
           patient group.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 7, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">June 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in total pulmonary resistance (TPR) from rest to exercise</measure>
    <time_frame>2nd minute,4th minute, 6th minute, 8th minute</time_frame>
    <description>The patient undergoes right heart catheterization and all hemodynamic variables are measured at rest and at exercise. TPR is derived by the following equation : mean pulmonary artery pressure/ cardiac output (mPAP/CO). TPR is measured at rest and at exercise following a specific protocol. The measurements are made at rest, then at the sequential exercise steps of increasing work resistance.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Exercise Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>normal rest and exercise hemodynamics</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>normal rest and abnormal exercise hemodynamics</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>resting pulmonary hypertension</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>abnormal wedge pressure at exercise</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are currently followed up in the Respiratory Clinics of the investigator's
        hospital and will be enrolled if suitable after having signed the form of consent.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. diagnosis of pulmonary fibrosis secondary to connective tissue disease, according to
             the American College of Rheumatology/European League Against Rheumatism (ACR-EULAR)
             revised classification criteria , or diagnosis of idiopathic fibrotic diffuse
             pulmonary disease according to American Thoracic Society/European Respiratory Society
             (ATS/ERS) guidelines

          2. Forced vital capacity (FVC) ≥ 40 %

        Exclusion Criteria:

          1. Presence of contra-indications to exercise tests, such as acute myocardial infarction,
             unstable angina, uncontrollable arrythmia or skeletal disease that limits the ability
             to exercise.

          2. History of pulmonary embolism during the year before enrollment

          3. Presence of severe valvular disease.

          4. Current treatment with vasoactive drugs of the pulmonary circulation

          5. Pulmonary wedge pressure (PAWP) at rest &gt; 15 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georgia G Pitsiou, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aristotle University Of Thessaloniki</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evangelia S Panagiotidou, MD</last_name>
    <phone>+306949139509</phone>
    <email>evangeliapanagiotidou@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georgia G Pitsiou, MD, PhD</last_name>
    <email>gpitsiou@yahoo.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>G.H. G. Papanikolaou</name>
      <address>
        <city>Thessaloniki</city>
        <state>Asvestochori</state>
        <zip>57010</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evangelia S Panagiotidou, MD</last_name>
      <phone>+306949139509</phone>
      <email>evangeliapanagiotidou@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <results_reference>
    <citation>Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H. An official European Respiratory Society statement: pulmonary haemodynamics during exercise. Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.</citation>
    <PMID>29167297</PMID>
  </results_reference>
  <results_reference>
    <citation>Herve P, Lau EM, Sitbon O, Savale L, Montani D, Godinas L, Lador F, Jaïs X, Parent F, Günther S, Humbert M, Simonneau G, Chemla D. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J. 2015 Sep;46(3):728-37. doi: 10.1183/09031936.00021915. Epub 2015 May 28.</citation>
    <PMID>26022955</PMID>
  </results_reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 16, 2018</study_first_posted>
  <last_update_submitted>October 11, 2018</last_update_submitted>
  <last_update_submitted_qc>October 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>EVAGGELIA PANAGIOTIDOU</investigator_full_name>
    <investigator_title>Phd candidate, Resident of Pulmonary medicine, G.H.G.Papanikolaou, Thessaloniki, Greece</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

